An observational study in Diabetic Neuropathies, sponsored by Universitas Diponegoro. Completed at 1 site in Indonesia. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-08-29.
Sponsored by Universitas Diponegoro · Observational
The goal of this clinical trial is to learn the differences severity level of diabetic neuropathy based on electromyelography in type II diabetic patient with and without comorbidities. The main questions of this study:
Researchers will collect information based on hospital registry as secondary data of in type II diabetic patient with and without comorbidities. The data consist of demographic data, clinical presentation, laboratory, and electromyography were collected from hospital registry by reviewing medical record. Then, the data was analyzed by using IBM SPSS Statistics v26.
1,003 studies on the registry are indexed under Peripheral Nervous System Diseases; 177 are open to participants now.
This study's enrollment of 78 is below the median of 90 across 188 observational studies indexed under Peripheral Nervous System Diseases.
Browse Peripheral Nervous System Diseases studies →Universitas Diponegoro is the lead sponsor of 23 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patient with type II diabetic mellitus who suffered diabetic neuropathy which diagnosed by using electromyography and fulfill the eligibility criteria
Exclusion Criteria:
Patient who suffered diabetic neuropathy and history of type II diabetic mellitus without comorbidities
Diagnostic Test: Electromyography
Patient who suffered diabetic neuropathy and history of type II diabetic mellitus with hypertension
Diagnostic Test: Electromyography
Patient who suffered diabetic neuropathy and history of type II diabetic mellitus with hypertension and dyslipidemia
Diagnostic Test: Electromyography
All of groups will have assessment of electromyography result
Distal Latency
Distal latency defined as time between stimuli until deflection of Compound Muscle Action Potentials (CMAP) from baseline
Time frame: Electromyography examination was done approximately 1 year after clinical onset of neuropathy appear
Nerve Conduction Velocity
Nerve Conduction Velocity defined as the measurement of axon conduction velocity by dividing space of nerve conduction with time needed
Time frame: Electromyography examination was done approximately 1 year after clinical onset of neuropathy appear
Amplitude
Amplitude define as the height of first negative deflection of Compound Muscle Action Potentials (CMAP) from baseline
Time frame: Electromyography examination was done approximately 1 year after clinical onset of neuropathy appear
Plan to share: No
This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peripheral Nervous System Diseases→
Universitas Diponegoro